Related Experiment Video
Updated: Jun 5, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[STAT3 and ras-MAPK signal transduction pathway in non-small cell lung cancer]
Zhenfa Zhang1, Jianqun Ma, Lin Zhang
1The First Affiliated Hospital of China Medical University, Shen Yang, Liao Ning 110001, P.R.China.
Background:
Biochemical and genetic researches suggest that ras protein plays an important role in transduction process of cell proliferation differentiation signals from activated transmembrane receptors to substream protein kinases. This study is to explore the expression of ras, p38, both of which are members of MAPK (mitogen activated protein kinases) signal transduction pathway, and STAT3 (signal transducer and activator of transcription 3) in non-small cell lung cancer, and the association among them.
Methods:
Forty-two resected lung cancer and paracancerous lung tissue samples were used to determine the protein expression of ras, p38 and STAT3 with Western blot, the mRNA expression of p38 and STAT3 in lung cancer tissues of various ras protein expression with RT-PCR. The location of p38 and STAT3 in lung cancer tissues was revealed with immunofluorescent staining.
Results:
The relative protein expressions of ras, p38 and STAT3 were 0.6012, 0.6724, 0.5119 in cancer tissues, and 0.2793, 0.3071, 0.1917 in paracancerous lung tissues, respectively (P < 0.01). The protein and mRNA expressions of p38 and STAT3 ( 0.7624 and 0.6262; 1.0309 and 1.0538) in cancer tissues with higher ras protein expression were remarkably higher than those with lower ras protein expression (0.4715 and 0.2569; 0. 6569 and 0.3437, P < 0.01). There was a significant correlation between the expression of ras, p38 and STAT3 (correlation coefficient: 0.809 and 0.842, P < 0.01), and so was the p38 and STAT3 (correlation coefficient: 0.829, P < 0.01).
Conclusions:
Abnormal expressions of STAT3 and some factors of ras-MAPK signal transduction pathway exist in the oncogenesis and development of non-small cell lung cancer, and many of them may have crosstalk.
Insights
Ras, p38, and STAT3 (signal transducer and activator of transcription 3) proteins are significantly upregulated in non-small cell lung cancer. Their abnormal expressions correlate with cancer development, suggesting pathway crosstalk.
Area of Science:
- Molecular Biology
- Oncology
- Signal Transduction
Context:
- Ras protein is crucial for cell proliferation and differentiation signal transduction.
- Mitogen-activated protein kinases (MAPK) pathways, including p38, are implicated in cancer.
- Signal transducer and activator of transcription 3 (STAT3) is a key signaling molecule in cancer.
Purpose:
- To investigate the expression of ras, p38, and STAT3 in non-small cell lung cancer (NSCLC).
- To explore the association between ras, p38, and STAT3 expression in NSCLC.
- To determine the role of these proteins in NSCLC oncogenesis and development.
Summary:
- Ras, p38, and STAT3 protein and mRNA levels were significantly higher in NSCLC tissues compared to paracancerous tissues.
- Higher ras protein expression was associated with significantly increased p38 and STAT3 expression (both protein and mRNA).
- Strong positive correlations were observed between ras, p38, and STAT3 expression, indicating pathway crosstalk.
Impact:
- Abnormal expression of ras-MAPK pathway factors and STAT3 is linked to NSCLC oncogenesis.
- Findings suggest potential therapeutic targets within the ras-MAPK/STAT3 signaling axis for NSCLC.
- Understanding these molecular interactions can lead to improved diagnostic and prognostic markers for NSCLC.
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
The JAK-STAT Signaling Pathway
The Ras Gene
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
